￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Who is Ibrutinib capsule suitable for treating?

2026-02-01 22:25:32

Check Details
When should ibrutinib capsules be discontinued?

2026-02-01 22:25:32

Check Details
Aceminid Dosing Guide + Maximum Dose, Adjustments

2026-02-01 22:25:32

Check Details
Aceminib shows sustained response rate in patients with chronic myelogenous leukemia at 48 weeks of follow-up

2026-02-01 22:25:32

Check Details
Aceminib outperforms standard TKIs in phase III chronic myeloid leukemia trial

2026-02-01 22:25:32

Check Details
Breakthrough progress in the treatment of Ph-positive chronic myelogenous leukemia with Aceminib

2026-02-01 22:25:32

Check Details
Aceminib used to treat chronic myelogenous leukemia in adults

2026-02-01 22:25:32

Check Details
Is Mobotinib (Mobosetinib) available in China?

2026-02-01 22:25:32

Check Details
Mobosetinib succinate capsule dosage price domestic selling price

2026-02-01 22:25:32

Check Details
Is there any medical insurance for Moboxetinib Succinate Capsules?

2026-02-01 22:25:32

Check Details
How long does it usually take to take Mobotinib?

2026-02-01 22:25:32

Check Details
Mobotinib (mobosetinib) side effects and hazards

2026-02-01 22:25:32

Check Details
Category
相关知识